Contact us

Leading CDMO Companies in Switzerland

Your Trusted Swiss Partners for Contract Manufacturing and Development

Applied Filters:Europe×Clear All
Showing 12 facilities
SENN Chemicals | R&D and Kilo Lab | Dielsdorf, Switzerland
Switzerland

SENN Chemicals | R&D and Kilo Lab | Dielsdorf, Switzerland

Senn Chemicals

Swiss peptide and peptide intermediates R&D site with SPPS, LPPS, hybrid synthesis, kilo lab scale up, purification and analytics.

BATCH SIZE: Small

CATEGORY / PRODUCT: COSMETICS, SERVICES, PARTICLE ENGINEERING, CHEMICAL-SYNTHETIC

REGION: Europe

SERVICES: Analytical / QC services, Logistics, Manufacturing services, Regulatory services, Development services, Packaging, Quality Assurance services

SENN Chemicals | Small Scale GMP Lab | Dielsdorf, Switzerland
Switzerland

SENN Chemicals | Small Scale GMP Lab | Dielsdorf, Switzerland

Senn Chemicals

Small scale GMP peptide and organic synthesis lab for clinical, niche and high value projects requiring flexible cGMP production.

BATCH SIZE: Small

REGION: Europe

SERVICES: Analytical / QC services, Logistics, Manufacturing services, Regulatory services, Development services, Packaging, Quality Assurance services

CATEGORY / PRODUCT: PARTICLE ENGINEERING, CHEMICAL-SYNTHETIC

SENN Chemicals | GMP Production | Dielsdorf, Switzerland
Switzerland

SENN Chemicals | GMP Production | Dielsdorf, Switzerland

Senn Chemicals

Swiss cGMP production site for LPPS, SPPS and hybrid peptide manufacturing from pilot to early commercial scale.

BATCH SIZE: Medium, Large

REGION: Europe

SERVICES: Analytical / QC services, Logistics, Manufacturing services, Regulatory services, Development services, Packaging, Quality Assurance services

CATEGORY / PRODUCT: PARTICLE ENGINEERING, CHEMICAL-SYNTHETIC

CARBOGEN AMCIS | Vionnaz
Switzerland

CARBOGEN AMCIS | Vionnaz

CARBOGEN AMCIS

Highly Potent APIs development and small-scale cGMP production including chromatography and lyophilization.

BATCH SIZE: Small

COMPLIANCE: EMA (EU GMP), PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), World Health Organization (GMP / HACCP), FDA (cGMP), ISO

REGION: Europe

MARKETS: ANVISA (Brazil), PMDA (Japan), FDA (USA), CDSCO (India), EMA (EU), MFDS (South Korea), TGA (Australia), NMPA (China), Health Canada (Canada), MHRA (UK)

USE: Human, Veterinary

SERVICES: Analytical / QC services, Manufacturing services, Development services, Quality Assurance services

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 1 / low-hazard (PDE > 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)

CATEGORY / PRODUCT: CHEMICAL-SYNTHETIC

CARBOGEN AMCIS | Neuland
Switzerland

CARBOGEN AMCIS | Neuland

CARBOGEN AMCIS

Development and medium scale manufacturing.

MARKETS: Turkish Health Authorities, ANVISA (Brazil), PMDA (Japan), FDA (USA), CDSCO (India), EMA (EU), MFDS (South Korea), TGA (Australia), NMPA (China), Health Canada (Canada), MHRA (UK)

BATCH SIZE: Small, Medium

COMPLIANCE: PMDA/MHLW (Japan GMP), World Health Organization (GMP / HACCP), FDA (cGMP)

CATEGORY / PRODUCT: SERVICES, CHEMICAL-SYNTHETIC

REGION: Europe

USE: Human, Veterinary

SERVICES: Analytical / QC services, Manufacturing services, Regulatory services, Development services, Quality Assurance services

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)

CARBOGEN AMCIS | Aarau
Switzerland

CARBOGEN AMCIS | Aarau

CARBOGEN AMCIS

Development and medium scale cGMP manufacturing including chromatography.

BATCH SIZE: Small, Medium

COMPLIANCE: PMDA/MHLW (Japan GMP), World Health Organization (GMP / HACCP), FDA (cGMP), ISO

CATEGORY / PRODUCT: SERVICES, PARTICLE ENGINEERING, BIOLOGICS, CHEMICAL-SYNTHETIC

REGION: Europe

MARKETS: ANVISA (Brazil), PMDA (Japan), FDA (USA), CDSCO (India), EMA (EU), MFDS (South Korea), TGA (Australia), NMPA (China), Health Canada (Canada), MHRA (UK)

USE: Human, Veterinary

SERVICES: Analytical / QC services, Manufacturing services, Development services, Quality Assurance services

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

CARBOGEN AMCIS | Bubendorf
Switzerland

CARBOGEN AMCIS | Bubendorf

CARBOGEN AMCIS

Development and cGMPmanufacturing of Highly Potent API including Antibody Drug Conjugates (ADC).

MARKETS: DIGEMID (Peru), ANMAT (Argentina), Turkish Health Authorities, ANVISA (Brazil), ISP (Chile), PMDA (Japan), FDA (USA), MSPAS (Guatemala), CDSCO (India), EMA (EU), COFEPRIS (Mexico), MFDS (South Korea), TGA (Australia), NMPA (China), Health Canada (Canada), INVIMA (Colombia), MHRA (UK)

BATCH SIZE: Small, Medium

THERAPEUTIC AREAS OF EXPERTISE (ATC): (R) Respiratory system, (V09-10) Radiopharmaceuticals, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (C) Cardiovascular system, (A) Digestive tract and metabolism, (D) Dermatologicals, (N) Nervous system, (B) Blood and blood forming organs

COMPLIANCE: EMA (EU GMP), PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), World Health Organization (GMP / HACCP), FDA (cGMP), ISO

CATEGORY / PRODUCT: SERVICES, PARTICLE ENGINEERING, BIOLOGICS, CHEMICAL-SYNTHETIC

REGION: Europe

USE: Human, Veterinary

SERVICES: Analytical / QC services, Manufacturing services, Regulatory services, Development services, Quality Assurance services

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 1 / low-hazard (PDE > 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)

Aenova Group - Location Sisseln, Switzerland
Switzerland

Aenova Group - Location Sisseln, Switzerland

Aenova

Competence Center complex conventional solids.

MARKETS: Turkish Health Authorities, ANVISA (Brazil), FDA (USA), Russian Health Authorities, MFDS (South Korea)

BATCH SIZE: Small, Medium, Large

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS, NUTRACEUTICALS

COMPLIANCE: Roszdravnadzor (Russia GMP), ANVISA (Brazil B-GMP), World Health Organization (GMP / HACCP), FDA (cGMP), ISO, MFDS/KFDA (Republic of Korea GMP)

REGION: Europe

USE: Human

SERVICES: Analytical / QC services, Manufacturing services, Regulatory services, Development services, Packaging, Quality Assurance services

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)

Aenova Group - Location Kirchberg, Switzerland
Switzerland

Aenova Group - Location Kirchberg, Switzerland

Aenova

Competence Center Soft gelatin capsules.

MARKETS: Turkish Health Authorities, FDA (USA), Russian Health Authorities, EMA (EU), MFDS (South Korea), SFDA (Saudi Arabia), TGA (Australia)

BATCH SIZE: Small, Medium, Large

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS, COSMETICS, NUTRACEUTICALS

COMPLIANCE: Roszdravnadzor (Russia GMP), EMA (EU GMP), World Health Organization (GMP / HACCP), TGA (Australia GMP), FDA (cGMP), SFDA (Saudi Food & Drug Authority), ISO, TITCK (Turkish Health Authorities), MFDS/KFDA (Republic of Korea GMP)

REGION: Europe

USE: Human, Veterinary

SERVICES: Analytical / QC services, Logistics, Manufacturing services, Regulatory services, Development services, Packaging, Quality Assurance services

THERAPEUTIC AREAS OF EXPERTISE (ATC): (H) Systemic hormonal preparations excl. sex hormones and insulins, (G) Genito urinary system and sex hormones, (C) Cardiovascular system, (A) Digestive tract and metabolism, (D) Dermatologicals, (V06) Nutrients

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 1 / low-hazard (PDE > 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)

Adragos Pharma | Jura
Switzerland

Adragos Pharma | Jura

Adragos Pharma

We specialize in aseptic manufacturing of lyophilized or liquid sterile (bio)pharmaceutical drug products through fill and finish.

BATCH SIZE: Small, Medium

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS

COMPLIANCE: EMA (EU GMP), FDA (cGMP)

REGION: Europe

USE: Human

SERVICES: Analytical / QC services, Logistics, Manufacturing services, Regulatory services, Development services, Packaging, Quality Assurance services

MARKETS: PMDA (Japan), FDA (USA), EMA (EU), MFDS (South Korea), NMPA (China), Health Canada (Canada), MHRA (UK)

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)

CONTROLLED SUBSTANCES: High potential for abuse & no medical use

Ophtapharm, a Sentiss Company
Switzerland

Ophtapharm, a Sentiss Company

Ophtapharm, a Sentiss Company

Ophtalmic and Otic - Solutions, suspensions, emulsions, ointments and gels - FDA Approved facility.

BATCH SIZE: Small, Medium, Large

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS

COMPLIANCE: EMA (EU GMP), World Health Organization (GMP / HACCP), FDA (cGMP), ISO

REGION: Europe

USE: Human, Veterinary

SERVICES: Analytical / QC services, Manufacturing services, Regulatory services, Development services, Packaging, Quality Assurance services

MARKETS: FDA (USA), EMA (EU)

Limited view

FDF / DRUG PRODUCTS manufacturing site

MAI network supplier

Contract Service Unit of a Swiss Biopharmaceutical Company that identifies, develops, and markets novel products in rare and ultra-rare diseases globally.

Location available after registration

Switzerland has earned its place as a global pharmaceutical powerhouse, renowned for precision, quality, and innovation. When it comes to contract development and manufacturing organizations (CDMOs), the country stands out for its advanced infrastructure, regulatory excellence, and experienced workforce. Partnering with CDMOs in Switzerland ensures access to some of the most reliable and technologically advanced manufacturing capabilities in Europe and beyond.

Whether you´re a biotech startup or a large pharmaceutical brand looking to outsource development, formulation, or production, Swiss CDMOs offer a strategic advantage in bringing your products to market efficiently and compliantly.


Why Choose CDMO Companies in Switzerland?

Switzerland offers an unmatched combination of pharmaceutical heritage, regulatory excellence, and technical know-how. Here´s why companies worldwide choose to work with CDMOs in Switzerland:

  • Regulatory Expertise: Swiss CDMOs operate under strict compliance with EMA, FDA, and Swissmedic guidelines, ensuring high global standards.
  • Innovation Hub: Home to pharmaceutical giants and R&D centers, Switzerland fosters constant innovation and advanced capabilities in biologics, sterile manufacturing, and high-potency compounds.
  • Strategic Location: Situated in the heart of Europe, Swiss CDMOs offer efficient logistics for global supply chains.
  • Skilled Workforce: With a deep pool of scientific and technical talent, Swiss CDMOs ensure your project is in capable hands from development through commercialization.

Key Services Offered by Swiss Contract Manufacturers

CDMOs in Switzerland provide a wide range of end-to-end pharmaceutical services, including:

  • Drug Development: Pre-formulation, analytical development, process optimization
  • Clinical Manufacturing: Small-batch production under GMP conditions for clinical trials
  • Commercial Manufacturing: Large-scale production for global markets, including packaging and labeling
  • Sterile & Aseptic Manufacturing: Injectable, ophthalmic, and other sterile dosage forms
  • Biologics & Biosimilars: Cell line development, upstream/downstream processing
  • High Potency & Controlled Substances: Specialized containment and safety infrastructure
  • Quality Assurance & Regulatory Support: Assistance with filings and audits

Swiss CDMOs often specialize in niche or complex areas, such as orphan drugs, nanoparticle delivery systems, and high-barrier generics.


Advantages of Partnering with CDMOs in Switzerland

Choosing a Swiss CDMO can offer numerous strategic and operational benefits:

  • Quality Without Compromise: Swiss precision is more than a cliché—it’s a pharmaceutical standard.
  • Accelerated Timelines: Streamlined regulatory pathways and efficient project management help reduce time to market.
  • Trust & Transparency: Swiss business culture emphasizes long-term partnerships and ethical practices.
  • Technological Edge: Cutting-edge facilities and digital manufacturing integration deliver operational excellence.
  • Global Compliance: Seamless adherence to global regulatory requirements, simplifying market access.

CDMO Companies in Switzerland

Some of the top CDMOs in Switzerland include:

Aenova: Competence Center for soft gelatin capsules in Switzerland. [See CDMO profile]

Ophtapharm, a Sentiss Company: CDMO in Switzerland for ophthalmic and otic solutions, suspensions, emulsions, ointments, and gels. [See CDMO profile]

APR LAB: Contract Service Unit of a Swiss biopharmaceutical company focused on identifying, developing, and marketing innovative treatments for rare and ultra-rare diseases worldwide. [See CDMO profile]

Adragos Pharma: Specializing in aseptic manufacturing of lyophilized and liquid sterile (bio)pharmaceutical drug products through fill-and-finish processes. [See CDMO profile]

CARBOGEN AMCIS: Expert in the development and cGMP production of highly potent APIs at small and medium scale, including chromatography and lyophilization capabilities. [See CDMO profile]


Related Information

Leading CDMO Companies in Europe

Leading CDMO Companies in Germany

Leading CDMO Companies in Italy

Leading CDMO Companies in France


Let MAI CDMO Network Help You Find the Right Swiss Partner

At MAI CDMO, we specialize in connecting pharmaceutical and biotech companies with the most suitable CDMOs in Switzerland. Whether you´re seeking a partner for complex biologic manufacturing or early-phase development support, we streamline the process of finding, qualifying, and engaging with the right Swiss CDMO for your needs.

Ready to explore your options? Contact us today and let’s help you find a Swiss partner that meets your timeline, quality standards, and growth goals.